APSR2026-1007

 
Late-Breaking
Submitted
Oral Presentation
AO28-006
 
 
https://storage.unitedwebnetwork.com/files/1285/1243936-46903-APSR26_Yiding Zhuang_433431.pptx
Format: PPTX Only
 
Format: PDF Only
09. Asthma
2

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Yiding Zhuang * National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention Division of Vital Registration and Death Cause Surveillance Beijing China
Peng Yin - National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention Division of Vital Registration and Death Cause Surveillance Beijing China
 
 
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Yiding
Zhuang
zhuangyiding22@163.com
+8613918862503
Under 30
China
Original Research
Projections of asthma prevalence in China and its provinces to 2050: a comprehensive approach using risk factors and sociodemographic modelling
Maximum 25 words
Abstract Content
Asthma prevalence in China has risen persistently, imposing a substantial health burden, particularly among children and older adults. We aimed to project trends in asthma prevalence and disability-adjusted life year (DALYs) through 2050 at national and provincial levels in China to inform health-care planning.
Using the latest available Global Burden of Disease 2023 estimates, updated on April 28, 2026, we developed a forecasting framework incorporating risk-factor and sociodemographic components. Four GBD 2023 risk factors, including high body-mass index, occupational asthmagens, secondhand smoking, and smoking, were integrated into a composite risk scalar, while the non-risk component was modelled as a function of the Sociodemographic Index via logit-linear approach. Model performance were trained on 1990–2013 and validated against 2014–2023 data. Projections were generated by province, sex, and age group through 2050, with 500 draw-level simulations to propagate uncertainty intervals (UIs).
The forecasting framework demonstrated robust predictive validity, with an R² of 0.77 and a mean absolute percentage error of 14.4% for asthma prevalence and 11.1% for DALYs. China's age-standardized asthma prevalence rate is projected to increase from 3,066.8 (95% UI: 2,529.4–3,675.7) per 100,000 in 2023 to 3,324.6 (2,646.2–4,228.6) in 2050, remaining higher in males. In contrast, age-standardized DALYs are projected to decline. Hong Kong, Inner Mongolia, and Qinghai are projected to remain among the provinces with the highest asthma burden. Older age groups bore the heaviest DALY burden overall. Notably, children aged 5–9 years in Shanghai (632.5, 348.53–1,083.1) and Hong Kong (416.3, 211.9–774.1) showed elevated DALYs by 2050.
Based on historical trends without future intervention effects, projected prevalence will continue rising with persistent DALY burdens in certain regions and pediatric groups, highlighting the need for scenario-based studies to guide targeted asthma burden reduction in China.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Asthma, Forecasting, China
maximum 3 keywords and no abbreviations, separated by commas
The authors gratefully acknowledge the Global Burden of Disease collaborators and the Institute for Health Metrics and Evaluation (IHME) for maintaining and updating the Global Health Data Exchange (GHDx) query tool. The most recent GHDx release (modified April 28, 2026) included updated estimates of disease burden and associated risk factors in China that were directly relevant to this study. To incorporate these newly available data and update all analyses accordingly, we chose to submit this study as a late-breaking abstract. The authors declare no competing interests.
313